Drug Profile
IN ALRN 001
Alternative Names: IN-ALRN-001Latest Information Update: 08 Sep 2016
Price :
$50
*
At a glance
- Originator Intas Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Benign prostatic hyperplasia
Most Recent Events
- 08 Sep 2016 No development reported - Phase-III for Benign prostatic hyperplasia in India (unspecified route)